Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Finding Could Improve Safety of Stem Cell Transplants

30.11.2004


Neuroprogenitor cells in culture that will become neurons.


Cells in culture with neurons stained green, supporting glial cells stained red and cell nuclei stained blue.


A lipid that helps destroy potentially harmful cells during brain development shows promise for improving the safety and efficacy of stem cell transplants, say researchers at the Medical College of Georgia and University of Georgia.

When embryonic stem cells are being coaxed toward becoming brain cells that could be transplanted, that lipid, ceramide, helps eliminate cells that could later form tumors called teratomas, researchers say in the Nov. 22 issue of The Journal of Cell Biology.

“The body has amazing mechanisms to eliminate cells that are no longer wanted and that if they remain will harm the body by developing into tissues that are not meant to be,” says Dr. Erhard Bieberich, MCG biochemist and the study’s lead author. “Our studies show this particular mechanism can help stem cells safely become the cells we want them to be.” “This is another approach to controlling differentiation and getting the cell types that you want,” says Dr. Brian G. Condie, developmental neurobiologist at UGA and MCG and senior author on the paper.



While it’s the ability of embryonic stem cells to make all types of tissue -- from brain cells to heart cells -- that has scientists worldwide exploring their potential to treat devastating diseases, their pluripotency can also be harmful if uncontrolled, says Dr. Bieberich.

Drs. Bieberich and Condie demonstrated in the Aug. 4, 2003 issue of The Journal of Cell Biology that a natural process occurs during development to eliminate excessive and potentially harmful cells. Just before neurons begin forming, there is a massive production of proteins and up-regulation of lipids. At that point, about half the cells have high levels of the protein PAR-4, half have high levels of the protein, nestin, and all have high levels of ceramide.

The researchers found cells that inherited PAR-4 died when partnered with ceramide. Fortunately, the nestin-bearing cells are most likely to become neurons while the PAR-4 cells, should they survive, could contribute to brain malformation. In this new paper, they took their findings in mouse embryonic stem cells and also looked at an approved line of human embryonic stem cells available through the National Institutes of Health Embryonic Stem Cell Registry.

Neuroprogenitor cells in culture that will become neurons. Cells in culture with neurons stained green, supporting glial cells stained red and cell nuclei stained blue. They found as the cells differentiated in culture, those containing PAR-4 have yet another bad dance card. “We have discovered that particular cells derived from embryonic stem cells that express PAR-4 also cause teratoma formation,” says Dr. Bieberich of the mostly benign growths comprised of multiple types of tissue, typically none of which belong in the tissue where they are found.

They found PAR-4-expressing cells also express Oct-4, a transcription factor that controls a cell’s ability to develop into all three basic types of tissue: mesoderm, ectoderm and endoderm. “If Oct-4 is expressed, the cells are still pluripotent, which is good if you want to grow all those kinds of embryonic layers,” says Dr. Bieberich. “But if you transplant them, you are at risk of forming teratomas.” However, at least in the culture dish, when they added PAR-4’s lethal dance partner, ceramide, to the mix, PAR-4- and Oct-4-expressing cells again died before they could do harm.

The ceramide analogue, N-oleoyl serinol, or S18, also increased the proportion of nestin-containing cells in cell cultures and grafts.

Drs. Bieberich and Condie were quick to note that in their studies, they intentionally left PAR-4- and Oct-4-bearing cells in the mix to see if they could eliminate them. “There already are ways to grow stem cells, purify them in cell culture and get a pure population of stem cells that you can transplant,” says Dr. Condie. “You want to make those cells differentiate into a particular cell type that is no longer able to form teratomas,” Dr. Bieberich says of this purification. “Having said that, that may not always be absolute.” “What we are trying to do is find ways that can be combined with those methods currently being used to further reduce the chances of teratoma formation and make stem cells extremely safe,” Dr. Condie says. “This is something that you want to have zero doubt about.” The next step is to look at an intact mouse embryo to see if the identical processes are at work.

The researchers’ work was funded by the NIH’s National Institute of Neurological Disorders and Stroke. Staff members of Dr. Bieberich’s lab, Dr. Jeane Silva, research coordinator; Dr. Guanghu Wang, research associate; and Kannan Krishnamurthy, graduate student; contributed to this work and co-author the publication.

Toni Baker | EurekAlert!
Further information:
http://www.mcg.edu

More articles from Life Sciences:

nachricht Hunting pathogens at full force
22.03.2017 | Helmholtz-Zentrum für Infektionsforschung

nachricht A 155 carat diamond with 92 mm diameter
22.03.2017 | Universität Augsburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Pulverizing electronic waste is green, clean -- and cold

22.03.2017 | Materials Sciences

Astronomers hazard a ride in a 'drifting carousel' to understand pulsating stars

22.03.2017 | Physics and Astronomy

New gel-like coating beefs up the performance of lithium-sulfur batteries

22.03.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>